Gas Exchange for Predicting Hospital Heart Failure Readmissions
1 other identifier
observational
120
1 country
7
Brief Summary
To determine whether, and if so, which gas exchange parameters measured on the Shape-HF Cardiopulmonary Exercise Testing System predict 30 and 180 day re-hospitalization in subjects discharged from hospitalization for an episode of acute decompensated heart failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2013
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 4, 2013
CompletedFirst Posted
Study publicly available on registry
October 10, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedApril 4, 2014
April 1, 2014
9 months
October 4, 2013
April 3, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
1. To evaluate if exercise gas exchange tests can predict 30 day hospital readmission for heart failure.
The analysis of exercise gas exchange (using the Shape-HF Cardiopulmonary Exercise Testing System) of the incidence of hospital readmission through 30 days ± 3 days post discharge follow-up.
30 days ± 3 days post discharge
2. To evaluate which gas exchange patterns were most highly associated with 30 day risk of readmission for recurrent acute decompensated heart failure.
The analysis of exercise gas exchange (using the Shape-HF Cardiopulmonary Exercise Testing System) of the incidence of hospital readmission through 30 days ± 3 days post discharge follow-up.
30 days ± 3 days post discharge
3. To determine the incidence of Adverse Events (AE) and Serious Adverse Events (SAE).
The analysis of the incidence of AEs and SAEs on the day of discharge post Shape-HF Cardiopulmonary Exercise Testing System through 30 days ± 3 days post discharge follow-up and through 180 days ± 15 days post discharge follow-up.
30 days ± 3 days post discharge follow-up and through 180 days ± 15 days post discharge
Secondary Outcomes (2)
1. To evaluate if exercise gas exchange tests can predict 180 day hospital readmission for heart failure.
180 days ± 15 days post discharge
2. To evaluate which gas exchange patterns were most highly associated with 180 day risk of readmission for recurrent acute decompensated heart failure.
180 days ± 15 days post discharge
Study Arms (1)
acute decompensated heart failure
Adult subjects anticipating discharge from a hospitalization where the primary discharge diagnosis is acute decompensated heart failure and who are not excluded due to existing conditions.
Eligibility Criteria
Subjects will be consecutively recruited from the population of subjects admitted to the hospital with acute decompensated heart failure.
You may qualify if:
- Subject is 18 Years and older
- Subject is hospitalized for acute decompensated heart failure (ADHF)
- Systolic OR
- Diastolic
- Subject is Stage C:Class II/III/IV heart failure
- Subject is willing and to provide appropriate informed consent
- Subject is willing and able to comply with the requirements of the protocol, including follow-up evaluations and schedule
- Subject is willing to use the Shape-HF Cardiopulmonary Exercise Testing System
You may not qualify if:
- The subject is pregnant (verified in a manner consistent with institution's standard of care)
- Subject is currently participating in another investigational device or drug trial
- Subject is a prisoner, a minor or unable to adequately give informed consent due to mental or physical condition
- Subject is unwilling or unable to return for the required follow-up after test
- Subject has Left Ventricular Assist Device (LVAD)
- Subject is listed for transplant
- Subject has a clinical diagnosis of acute myocardial infarction (AMI) on admission (Note: If troponin measurements have been collected and are elevated but not due to an MI subject is still eligible for study)
- Subject has a pulmonary embolism (PE) on admission
- Subject is dialysis dependent
- Subject has a cardiac resynchronization device (CRT) which has been re-programmed at any time during the study
- Subject has Chronic Obstructive Pulmonary Disease (COPD) who is oxygen or steroid dependent
- Subject has severe hypertension \> 180 millimeter of mercury (mmHg) resting systolic at time of test
- Subject has severe heart failure with renal insufficiency (with Creatinine clearance rate (CrCL) of 30 or less) and/or on IV Inotropic therapy and/or enrolling in hospice
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Veterans Affairs-Washington DC
Washington D.C., District of Columbia, 20422, United States
Christie Clinic
Champaign, Illinois, 61820, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Fairview Southdale
Edina, Minnesota, 55435, United States
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Washington University of Medicine
St Louis, Missouri, 63110, United States
Cleveland Clinic
Cleveland, Ohio, 44195, United States
Related Publications (4)
Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 2008 Aug 5;52(6):428-34. doi: 10.1016/j.jacc.2008.03.061.
PMID: 18672162BACKGROUNDPulignano G, Del Sindaco D, Tavazzi L, Lucci D, Gorini M, Leggio F, Porcu M, Scherillo M, Opasich C, Di Lenarda A, Senni M, Maggioni AP; IN-CHF Investigators. Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). Am Heart J. 2002 Jan;143(1):45-55. doi: 10.1067/mhj.2002.119608.
PMID: 11773911BACKGROUNDJacobs B. Reducing heart failure hospital readmissions from skilled nursing facilities. Prof Case Manag. 2011 Jan-Feb;16(1):18-24; quiz 25-6. doi: 10.1097/NCM.0b013e3181f3f684.
PMID: 21164330BACKGROUNDYu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005 Aug 9;112(6):841-8. doi: 10.1161/CIRCULATIONAHA.104.492207. Epub 2005 Aug 1.
PMID: 16061743BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Abraham G Kocheril, MD
Christie Clinc
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 4, 2013
First Posted
October 10, 2013
Study Start
October 1, 2013
Primary Completion
July 1, 2014
Study Completion
January 1, 2015
Last Updated
April 4, 2014
Record last verified: 2014-04